Vercise (Boston Scientific) receives CE mark approval for Dystonia
The Vercise deep brain stimulation system, from Boston Scientific, has received CE Mark approval in the EU for the treatment of intractable primary and secondary Dystonia. The Vercise DBS System is the first system designed to selectively stimulate targeted areas of the brain in order to customize therapy and manage symptoms.
The first implant of the Vercise DBS System for the treatment of Dystonia was performed by a team from the Charit� Campus Virchow-Klinikum, which included Prof. Dr. Andrea K�hn, Department of Neurology, and Dr. Gerd-Helge Schneider, Department of Functional Neurosurgery. Vercise is CE mark approved for the treatment of Parkinsons Disease.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.